- New Purchases: QURE, FIXX, EOLS, PSNL, ARQL, ADMA, UTHR, KZR,
- Added Positions: KURA, BMY, SBBP, ZBH, URGN, CLVS, CNC, NTEC, ALDX, CBIO, UROV, CDTX, SRRA,
- Reduced Positions: CI, WCG, HNGR, NVRO, ASGN, IOVA, RETA, ARNA, MLND, PRSC, ASMB, ACIU, MTEM, BMRN, ALBO, TLGT, NLTX,
- Sold Out: WAGE, MGNX, MGTX, CERC, ENTA,
For the details of Prosight Management, LP's stock buys and sells, go to https://www.gurufocus.com/guru/prosight+management%2C+lp/current-portfolio/portfolio
These are the top 5 holdings of Prosight Management, LP- Zimmer Biomet Holdings Inc (ZBH) - 164,619 shares, 9.86% of the total portfolio. Shares added by 33.29%
- Bristol-Myers Squibb Company (BMY) - 410,490 shares, 9.47% of the total portfolio. Shares added by 45.05%
- Kura Oncology Inc (KURA) - 867,810 shares, 8.69% of the total portfolio. Shares added by 401.93%
- Reata Pharmaceuticals Inc (RETA) - 124,965 shares, 5.99% of the total portfolio. Shares reduced by 28.88%
- Iovance Biotherapeutics Inc (IOVA) - 400,000 shares, 4.99% of the total portfolio. Shares reduced by 56.38%
Prosight Management, LP initiated holding in uniQure NV. The purchase prices were between $52.76 and $82.19, with an estimated average price of $63.55. The stock is now traded at around $56.90. The impact to a portfolio due to this purchase was 4.77%. The holding were 120,000 shares as of .
New Purchase: Homology Medicines Inc (FIXX)Prosight Management, LP initiated holding in Homology Medicines Inc. The purchase prices were between $18.35 and $30.34, with an estimated average price of $21.81. The stock is now traded at around $16.78. The impact to a portfolio due to this purchase was 3.67%. The holding were 369,048 shares as of .
New Purchase: Evolus Inc (EOLS)Prosight Management, LP initiated holding in Evolus Inc. The purchase prices were between $13.19 and $28.36, with an estimated average price of $19.84. The stock is now traded at around $14.05. The impact to a portfolio due to this purchase was 0.84%. The holding were 112,590 shares as of .
New Purchase: Personalis Inc (PSNL)Prosight Management, LP initiated holding in Personalis Inc. The purchase prices were between $27 and $30.25, with an estimated average price of $28.28. The stock is now traded at around $18.05. The impact to a portfolio due to this purchase was 0.78%. The holding were 56,446 shares as of .
New Purchase: Arqule Inc (ARQL)Prosight Management, LP initiated holding in Arqule Inc. The purchase prices were between $4.77 and $11.01, with an estimated average price of $6.96. The stock is now traded at around $8.96. The impact to a portfolio due to this purchase was 0.47%. The holding were 83,675 shares as of .
New Purchase: ADMA Biologics Inc (ADMA)Prosight Management, LP initiated holding in ADMA Biologics Inc. The purchase prices were between $3.52 and $5.24, with an estimated average price of $4.42. The stock is now traded at around $3.95. The impact to a portfolio due to this purchase was 0.37%. The holding were 185,721 shares as of .
Added: Kura Oncology Inc (KURA)Prosight Management, LP added to a holding in Kura Oncology Inc by 401.93%. The purchase prices were between $14.71 and $19.79, with an estimated average price of $16.58. The stock is now traded at around $17.83. The impact to a portfolio due to this purchase was 6.96%. The holding were 867,810 shares as of .
Added: Bristol-Myers Squibb Company (BMY)Prosight Management, LP added to a holding in Bristol-Myers Squibb Company by 45.05%. The purchase prices were between $44.62 and $49.34, with an estimated average price of $46.57. The stock is now traded at around $46.98. The impact to a portfolio due to this purchase was 2.94%. The holding were 410,490 shares as of .
Added: Strongbridge Biopharma PLC (SBBP)Prosight Management, LP added to a holding in Strongbridge Biopharma PLC by 172.73%. The purchase prices were between $2.82 and $4.96, with an estimated average price of $3.67. The stock is now traded at around $2.53. The impact to a portfolio due to this purchase was 2.57%. The holding were 2,546,997 shares as of .
Added: Zimmer Biomet Holdings Inc (ZBH)Prosight Management, LP added to a holding in Zimmer Biomet Holdings Inc by 33.29%. The purchase prices were between $112.14 and $128.84, with an estimated average price of $120.53. The stock is now traded at around $137.01. The impact to a portfolio due to this purchase was 2.46%. The holding were 164,619 shares as of .
Added: UroGen Pharma Ltd (URGN)Prosight Management, LP added to a holding in UroGen Pharma Ltd by 65.29%. The purchase prices were between $32.75 and $40.35, with an estimated average price of $36.86. The stock is now traded at around $32.01. The impact to a portfolio due to this purchase was 1.88%. The holding were 260,928 shares as of .
Added: Clovis Oncology Inc (CLVS)Prosight Management, LP added to a holding in Clovis Oncology Inc by 80.44%. The purchase prices were between $12.81 and $25.67, with an estimated average price of $18.09. The stock is now traded at around $5.60. The impact to a portfolio due to this purchase was 1.52%. The holding were 450,000 shares as of .
Sold Out: WageWorks Inc (WAGE)Prosight Management, LP sold out a holding in WageWorks Inc. The sale prices were between $38.05 and $52.76, with an estimated average price of $47.21.
Sold Out: Macrogenics Inc (MGNX)Prosight Management, LP sold out a holding in Macrogenics Inc. The sale prices were between $14.51 and $19.71, with an estimated average price of $17.19.
Sold Out: MeiraGTx Holdings PLC (MGTX)Prosight Management, LP sold out a holding in MeiraGTx Holdings PLC. The sale prices were between $17.38 and $26.88, with an estimated average price of $20.67.
Sold Out: Cerecor Inc (CERC)Prosight Management, LP sold out a holding in Cerecor Inc. The sale prices were between $4.49 and $6.22, with an estimated average price of $5.26.
Sold Out: Enanta Pharmaceuticals Inc (ENTA)Prosight Management, LP sold out a holding in Enanta Pharmaceuticals Inc. The sale prices were between $81.3 and $97.35, with an estimated average price of $89.96.
Here is the complete portfolio of Prosight Management, LP. Also check out:
1. Prosight Management, LP's Undervalued Stocks
2. Prosight Management, LP's Top Growth Companies, and
3. Prosight Management, LP's High Yield stocks
4. Stocks that Prosight Management, LP keeps buying